BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2947974)

  • 1. Temperature dependence of drug interaction with the platelet 5-hydroxytryptamine transporter: a clue to the imipramine selectivity paradox.
    Segonzac A; Schoemaker H; Langer SZ
    J Neurochem; 1987 Feb; 48(2):331-9. PubMed ID: 2947974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the temperature dependence of drug interaction with the noradrenaline and serotonin transporters.
    De Oliveira AM; Schoemaker H; Segonzac A; Langer SZ
    Neuropharmacology; 1989 Aug; 28(8):823-8. PubMed ID: 2528702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
    Graham D; Esnaud H; Habert E; Langer SZ
    Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition and dissociation of [3H]-paroxetine binding to human platelets.
    Andersson A; Marcusson J
    Neuropsychobiology; 1989; 22(3):135-40. PubMed ID: 2535005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]citalopram binding to brain and platelet membranes of human and rat.
    Plenge P; Mellerup ET
    J Neurochem; 1991 Jan; 56(1):248-52. PubMed ID: 1824783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity binding of [3H]6-nitroquipazine to 5-hydroxytryptamine transporter in human platelets.
    Hashimoto K; Goromaru T
    Eur J Pharmacol; 1990 Oct; 187(3):295-302. PubMed ID: 2073917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets.
    Plenge P; Mellerup ET; Laursen H
    Eur J Pharmacol; 1991 Mar; 206(3):243-50. PubMed ID: 1830276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes.
    Mellerup ET; Plenge P; Engelstoft M
    Eur J Pharmacol; 1983 Dec; 96(3-4):303-9. PubMed ID: 6233162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
    Galzin AM; Moret C; Verzier B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):200-11. PubMed ID: 2864432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.
    Langer SZ; Galzin AM; Poirier MF; Loo H; Sechter D; Zarifian E
    J Recept Res; 1987; 7(1-4):499-521. PubMed ID: 3040983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity of 25 paroxetine/femoxetine structure variants in various reactions, assumed to be important for the effect of antidepressants.
    Plenge P; Mellerup ET; Honoré T; Honoré PL
    J Pharm Pharmacol; 1987 Nov; 39(11):877-82. PubMed ID: 2892909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipramine binding site. Temperature dependence of the binding of 3H-labeled imipramine and 3H-labeled paroxetine to human platelet membrane.
    Plenge P; Mellerup ET
    Biochim Biophys Acta; 1984 Feb; 770(1):22-8. PubMed ID: 6230106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet [3H]paroxetine binding to 5-HT uptake sites in Alzheimer's disease.
    Andersson A; Adolfsson R; Eriksson K; Marcusson J
    Neurobiol Aging; 1991; 12(5):531-4. PubMed ID: 1837595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric interaction between the site labeled by [3H]imipramine and the serotonin transporter in human platelets.
    Meyerson LR; Ieni JR; Wennogle LP
    J Neurochem; 1987 Feb; 48(2):560-5. PubMed ID: 3491878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the serotonin transporter in platelets.
    Langer SZ; Galzin AM
    Experientia; 1988 Feb; 44(2):127-30. PubMed ID: 2964377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the 5-hydroxytryptamine transport across the plasma membrane of rabbit platelets and its inhibition by imipramine.
    Wölfel R; Böhm W; Halbrügge T; Bönisch H; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):1-8. PubMed ID: 3237251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of the interaction of sertraline with the human platelet plasma membrane 5-hydroxytryptamine carrier.
    Phillips OM; Wood KM; Williams DC
    Eur J Pharmacol; 1988 Feb; 146(2-3):299-306. PubMed ID: 3371401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High affinity binding of 3H-paroxetine and 3H-imipramine to rat neuronal membranes.
    Mellerup ET; Plenge P
    Psychopharmacology (Berl); 1986; 89(4):436-9. PubMed ID: 2944152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-step purification of the serotonin transporter located at the human platelet plasma membrane.
    Launay JM; Geoffroy C; Mutel V; Buckle M; Cesura A; Alouf JE; Da Prada M
    J Biol Chem; 1992 Jun; 267(16):11344-51. PubMed ID: 1534559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptine.
    Poirier MF; Galzin AM; Loo H; Pimoule C; Segonzac A; Benkelfat C; Sechter D; Zarifian E; Schoemaker H; Langer SZ
    Biol Psychiatry; 1987 Mar; 22(3):287-302. PubMed ID: 3028514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.